Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative subanesthetic esketamine for postoperative sleep disturbance in elderly patients undergoing laparoscopic gastrointestinal tumor resection
ChiCTR2400087222Phase 4Completed
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Postoperative sleep disturbance (PSD) (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoint: Incidence of sleep disturbance on postoperative day 1. Started Aug 2024; status: completed.
02
Drugs
esketamine
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on ChiCTR2400087222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087222.